Picture a press release celebrating two AI-based tools that succeeded with drug-retargeting tasks. Translation: both systems generated hypotheses, and one of them performed light data analysis.
The announcement treats plausible suggestions as genuine scientific output. In practice it is the digital equivalent of asking a bright intern to brainstorm repurposing ideas before anyone runs an experiment. The bar has been lowered so far that avoiding total nonsense now qualifies as progress.
Corporate language frames this as autonomous discovery. The reality is closer to prompt engineering dressed up with lab-adjacent vocabulary while validation, testing, and actual chemistry remain human responsibilities. Success here means the model did not crash and produced sentences that sound informed.
No one is questioning whether AI can output ideas quickly. The question is why basic hypothesis generation now earns headlines usually reserved for molecule approvals or clinical results.
